# Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink

> **NCT06551298** · NA · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 129 (estimated)

## Conditions studied

- Hyperlipidemias

## Interventions

- **OTHER:** Menggongzi Tibetan Tea Special Drink
- **DRUG:** Atorvastatin Calcium 20Mg Tab
- **OTHER:** Low fat diet

## Key facts

- **NCT ID:** NCT06551298
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-08-08
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06551298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06551298, "Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06551298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*